Our CD31 immunofluorescence data demonstrated that Exo treatment led to incremented CD31 expression at ulcer sites (Fig. 2E–F), suggesting that Exo treatment reversed HG-induced dysfunction. The gene discussed is PECAM1; the disease is ulcer disease.